Cargando…
Metabolic gene NR4A1 as a potential therapeutic target for non‐smoking female non‐small cell lung cancer patients
BACKGROUND: Although cigarette smoking is considered one of the key risk factors for lung cancer, 15% of male patients and 53% of female patients with lung cancer are non‐smokers. Metabolic changes are critical features of cancer. Therapeutic target identification from a metabolic perspective in non...
Autores principales: | Sun, Rong, Bao, Min‐Yue, Long, Xin, Yuan, Yuan, Wu, Miao‐Miao, Li, Xin, Bao, Jin‐Ku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449245/ https://www.ncbi.nlm.nih.gov/pubmed/30806032 http://dx.doi.org/10.1111/1759-7714.12989 |
Ejemplares similares
-
The expression and biological effect of NR2F6 in non-small cell lung cancer
por: Yang, Shu lin, et al.
Publicado: (2022) -
Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)
por: Zhou, Lei, et al.
Publicado: (2023) -
Smoking alters the evolutionary trajectory of non-small cell lung cancer
por: Yu, Xiao-Jun, et al.
Publicado: (2019) -
Therapeutic potential of NR4A1 in cancer: Focus on metabolism
por: Deng, Shan, et al.
Publicado: (2022) -
Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)